πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

19 results for β€œDong” Clear

  1. MB-102 DMID

    Hangzhou Zhongmei Huadong Pharmaceutical Co.,

    Kidney Diseases

    phase 3 small molecule completed

    1 trial

  2. Methylthioninium

    Shandong Suncadia Medicine Co.,

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  3. Telmisartan/Amlodipine

    Dong Wang

    Hypertension With Hyperlipidemia

    phase 3 small molecule completed

    1 trial

  4. evogliptin

    Dong Wang

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  5. DA-4001C

    Dong Wang

    Androgenetic Alopecia

    phase 2 small molecule completed

    1 trial

  6. HRS-7058

    Shandong Suncadia Medicine Co.,

    Pancreatic Cancer

    phase 2 small molecule active

    1 trial

  7. MSC

    Shandong University

    Type 2 Diabetes

    phase 2 mab active

    1 trial

  8. Amitriptyline Hydrochloride 25Mg Tablet（Hunan DongtingοΌ‰

    The First People's Hospital of Lianyungang

    Depressive Disorder

    phase 1 small molecule completed

    1 trial

  9. Aricept 5mg Tablet

    Dong Wang

    Healthy

    phase 1 small molecule active

    1 trial

  10. Bilateral Cerebellar deep brain stimulation

    Shandong Suncadia Medicine Co.,

    Stroke

    phase 1 other active

    1 trial

  11. DA-5210 10/500mg

    Dong Wang

    Healthy

    phase 1 small molecule completed

    1 trial

  12. paclitaxel cationic liposome for injection

    CSPC Baike (Shandong) Biopharmaceutical Co.,

    Colorectal Liver Metastases

    phase 1 small molecule active

    1 trial

  13. De-escalation strategy

    Dong Wang

    Acute Myocardial Infarction

    approved small molecule active

    1 trial

  14. Pramipexole

    Dong Jie

    Restless Legs Syndrome

    approved small molecule terminated

    1 trial

  15. Risedronate Sodium 35 MG [Actonel]

    Dong Wang

    Postmenopausal Osteoporosis

    approved small molecule completed

    1 trial

  16. placebo

    Shandong University

    Sedation

    approved small molecule active

    1 trial

  17. Mononuclear cells

    Shandong Provincial Hospital

    Chronic Atrophic Gastritis

    mab active

    1 trial

  18. bismuth-containing quadral therapy based on antibiotic susceptibility

    Shandong University

    Helicobacter Pylori

    small molecule active

    1 trial

  19. rivastigmine patch

    Dong Wang

    Alzheimer's Disease

    small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources